Table 2.
Mouse genotype | # of animals | % of mice with lung neoplasms | % of mice with multiple lung neoplasms | # of lung neoplasms per mouse† ± SD | Average lung neoplasm size (mm) ± SD | % of mice with lymphoma |
---|---|---|---|---|---|---|
Msh6−/−Rrm2Tg | 13 | 100%* | 69%* | 2.9 ± 1.99 | 1.30 ± 0.54 | 31% |
Msh6−/− | 13 | 15% | 0% | 1.0 ± 0 | 1.25 ± 1.06 | 8% |
Msh6+/−Rrm2Tg | 17 | 18% | 0% | 1.0 ± 0 | 0.73 ± 0.68 | 12% |
Msh6+/− | 10 | 0% | 0% | N/A | N/A | 0% |
Msh6+/+Rrm2Tg | 18 | 17% | 6% | 1.33 ± 0.58 | 1.23 ± 0.25 | 0% |
Msh6+/+ | 14 | 0% | 0% | N/A | N/A | 0% |
NOTE: Mice were aged for 6 months, euthanized by asphyxiation using carbon dioxide, and subjected to pathological examination as described in Materials and Methods. Only mice that lived to 6 months were included. Four Msh6−/−Rrm2Tg mice died before 6 months due to lymphoma, one of which also had a lung neoplasm. Four Msh6−/− mice died before 6 months due to lymphoma.
Values refer to the average number of lung neoplasms per mouse among tumor-bearing animals only.
Statistically significant difference (p<0.01) relative to Msh6−/−, Msh6+/−Rrm2Tg, or Msh6+/+Rrm2Tg mice as determined by Fisher’s Exact test.